966-P: Real-World Impact of AI-driven CGM Platform on Glycemic Status in Type 2 Diabetes—A Retrospective Study
Introduction and Objective: Artificial intelligence (AI)-powered diabetes management platforms integrating CGM technology represent a promising advancement in healthcare. This study evaluates the effectiveness of AI-integrated SDRMP platform in improving glycemic control. Methods: A 100-day retrospective study of 1752 individuals (1357 male, 395 female; mean age 50.22±11.33 years) assessed the...
Introduction and Objective: Artificial intelligence (AI)-powered diabetes management platforms integrating CGM technology represent a promising advancement in healthcare. This study evaluates the effectiveness of AI-integrated SDRMP platform in improving glycemic control. Methods: A 100-day retrospective study of 1752 individuals (1357 male, 395 female; mean age 50.22±11.33 years) assessed the...
Machine-ingested summary: the claims above reflect a single primary source and have not been weighed against contradicting evidence by a Truvace editor yet.
Evidence
- Peer-reviewedDiabetes2025-06-13
Truvace Impact Record TRV-2026-0016, v1: “966-P: Real-World Impact of AI-driven CGM Platform on Glycemic Status in Type 2 Diabetes—A Retrospective Study.” Truvace, 2026-07-11. /record/TRV-2026-0016 (accessed at citation time). sha256 52cd993d5c940295…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-0016 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.